Pacific Shuanglin Bio-Pharmacy Co.,Ltd.’s Net Profit Dropped 7.1% in First Three Quarters of 2023

Pacific Shuanglin Bio-Pharmacy Co.,Ltd. (派斯双林生物制药股份有限公司) (000403.SZ) reported a net profit of 325.8 million yuan in the first three quarters of 2023, down 7.1% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, down 7.9% year-on-year.

At the end of the reporting period, it had 8.2 billion yuan in total assets and 1.1 billion yuan in total liabilities, with a liability-to-asset ratio of 13.5%.